Catalyst
Recent Bullish Engulfing and WR Oversold signals in late November and early December point to rebound momentum for CVS.
Most analysts rate CVS Buy or Strong Buy, showing broad institutional optimism.
Risk
Fund flows show negative trends across all order sizes, indicating outflows and declining investor confidence.
Market expectations tend to be pessimistic, and analyst ratings remain inconsistent.
Generated at20:1212/04/2025by
Aime
